What is the catalog number for Plzf/ZBTB16 Rabbit Polyclonal Antibody?

The catalog number for Plzf/ZBTB16 Rabbit Polyclonal Antibody is orb371703.

What sizes are available for Plzf/ZBTB16 Rabbit Polyclonal Antibody?

Plzf/ZBTB16 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Plzf/ZBTB16 Rabbit Polyclonal Antibody in stock?

Plzf/ZBTB16 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Plzf/ZBTB16 Rabbit Polyclonal Antibody

Anti-Plzf/ZBTB16 Antibody. Tested in WB applications. This antibody reacts with Human, Rat.

Product Specifications

Product Name Alternative

Zinc finger and BTB domain-containing protein 16; Promyelocytic leukemia zinc finger protein; Zinc finger protein 145; Zinc finger protein PLZF; ZBTB16; PLZF, ZNF145

UniProt

Q05516

Reactivity

Human, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human Plzf recombinant protein (Position: M1-E165) .

Target

Zinc finger and BTB domain-containing protein 16

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Disease Biomarkers, Immunology & Inflammation, Protein Biochemistry, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Rat

Form

Lyophilized

Molecular Weight

74 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.